Literature DB >> 18635586

Treatments for tinnitus.

William Noble1.   

Abstract

The various forms of treatment for tinnitus that have been tested in properly controlled trials can be classified as pharmacological, acoustic-physical, and psychological. In clinical trials, no pharmacological agent has been shown to have lasting effect on the presence or severity of tinnitus, although there are promising signs in an animal model. Acoustic devices do not seem to influence tinnitus, although appropriately fitted hearing aids may slightly reduce its prominence. Of physical treatments, cortical implantation may hold some promise of being effective for tinnitus suppression in selected cases. A psychological treatment that has emerged as consistently beneficial is cognitive-behavior therapy in terms of affecting overall well-being and reducing level of tinnitus annoyance.

Entities:  

Mesh:

Year:  2008        PMID: 18635586      PMCID: PMC4134891          DOI: 10.1177/1084713808320552

Source DB:  PubMed          Journal:  Trends Amplif        ISSN: 1084-7138


  26 in total

1.  Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model.

Authors:  Thomas J Brozoski; T Joseph D Spires; Carol A Bauer
Journal:  J Assoc Res Otolaryngol       Date:  2007-01-13

Review 2.  Cognitive behavioural therapy for tinnitus.

Authors:  P Martinez Devesa; A Waddell; R Perera; M Theodoulou
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 3.  A critical analysis of directive counselling as a component of tinnitus retraining therapy.

Authors:  P H Wilson; J L Henry; G Andersson; R S Hallam; P Lindberg
Journal:  Br J Audiol       Date:  1998-10

4.  Treatment of tinnitus: a controlled comparison of masking and placebo.

Authors:  S Erlandsson; A Ringdahl; T Hutchins; S G Carlsson
Journal:  Br J Audiol       Date:  1987-02

5.  Effect of amplification on tinnitus among new hearing aid users.

Authors:  R K Surr; A A Montgomery; H G Mueller
Journal:  Ear Hear       Date:  1985 Mar-Apr       Impact factor: 3.570

6.  Tinnitus Handicap Inventory (THI) as a hearing aid outcome measure.

Authors:  R K Surr; J A Kolb; M T Cord; N P Garrus
Journal:  J Am Acad Audiol       Date:  1999-10       Impact factor: 1.664

7.  The functional neuroanatomy of tinnitus: evidence for limbic system links and neural plasticity.

Authors:  A H Lockwood; R J Salvi; M L Coad; M L Towsley; D S Wack; B W Murphy
Journal:  Neurology       Date:  1998-01       Impact factor: 9.910

8.  Treating chronic tinnitus: comparison of cognitive-behavioural and habituation-based treatments.

Authors:  Claudia Zachriat; Birgit Kröner-Herwig
Journal:  Cogn Behav Ther       Date:  2004

9.  Neuromonics Tinnitus Treatment: third clinical trial.

Authors:  Paul B Davis; Bardia Paki; Peter J Hanley
Journal:  Ear Hear       Date:  2007-04       Impact factor: 3.570

Review 10.  Tinnitus retraining therapy: a different view on tinnitus.

Authors:  Pawel J Jastreboff; Margaret M Jastreboff
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2006-03-03       Impact factor: 1.538

View more
  5 in total

1.  The Tinnitus Research Initiative (TRI) database: a new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome.

Authors:  Michael Landgrebe; Florian Zeman; Michael Koller; Yvonne Eberl; Markus Mohr; Jean Reiter; Susanne Staudinger; Goeran Hajak; Berthold Langguth
Journal:  BMC Med Inform Decis Mak       Date:  2010-08-03       Impact factor: 2.796

2.  A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus.

Authors:  Markus Suckfüll; Michael Althaus; Barbara Ellers-Lenz; Alexander Gebauer; Roman Görtelmeyer; Pawel J Jastreboff; Hans J Moebius; Tanja Rosenberg; Hermann Russ; Yvonne Wirth; Hagen Krueger
Journal:  BMC Ear Nose Throat Disord       Date:  2011-01-11

3.  Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA.

Authors:  Deborah A Hall; Miguel J A Láinez; Craig W Newman; Tanit Ganz Sanchez; Martin Egler; Frank Tennigkeit; Marco Koch; Berthold Langguth
Journal:  BMC Health Serv Res       Date:  2011-11-04       Impact factor: 2.655

4.  Flufenamic acid prevents behavioral manifestations of salicylate-induced tinnitus in the rat.

Authors:  Ramazan Bal; Yasemin Ustundag; Funda Bulut; Caner Feyzi Demir; Ali Bal
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

5.  Tinnitus services in the United Kingdom: a survey of patient experiences.

Authors:  Don McFerran; Derek J Hoare; Simon Carr; Jaydip Ray; David Stockdale
Journal:  BMC Health Serv Res       Date:  2018-02-13       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.